Takeshi Kawamura
Tokyo, 1130032, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.
Journal: Science translational medicine
Published: September 17, 2025
Antibody profiling and plasma proteomics in SARS-CoV-2 infection: a pilot study.
Journal: Scientific reports
Published: August 22, 2025
The Anti-Nucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection for Hemodialysis Patients.
Journal: Vaccines
Published: May 23, 2025
Discrepancy in SARS-CoV-2 Infection Status Among PCR, Serological, and Cellular Immunity Assays of Nucleocapsids: A Historical Cohort Study.
Journal: Vaccines
Published: January 01, 2025
Group of longitudinal adverse event patterns after the fourth dose of COVID-19 vaccination with a latent class analysis.
Journal: Frontiers in public health
Published: April 08, 2024
SARS-CoV-2 spike protein antibody titers after the fourth dose of BNT162b2 vaccine among Japanese patients undergoing hemodialysis: a single-center study.
Journal: Frontiers in immunology
Published: April 06, 2024
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan.
Journal: Frontiers in immunology
Published: June 15, 2023
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan.
Journal: Vaccines
Published: April 03, 2023
Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination.
Journal: Scientific reports
Published: February 27, 2023
Last Updated: 09/26/2026